New diabetes shot could cut injections in half

NCT ID NCT06849843

Completed Disease control Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new drug called efsubaglutide alfa in 59 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. Participants received either a 3mg injection every two weeks or a 1mg injection weekly for 12 weeks. The goal was to see if the twice-monthly dose could lower blood sugar levels as effectively as the weekly dose.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Efsubaglutide Alfa injection
What this could lead to: If it works, this could offer a more convenient, less frequent injection option for managing type 2 diabetes.
What could go wrong: This is a small, early-phase trial with only 59 participants. The drug may not prove effective or could have side effects. Results may not apply to all diabetes patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE2 DIABETES

Contacts and locations

Locations

CangZhou Hospital of Integrated TCM and Western Medicine in Hebei Province

Cangzhou, China
Huzhou Central Hospital

Huzhou, China
Jiangsu Province Offical Hospital

Nanjing, China
Nanjing First Hospital

Nanjing, Jiangsu, 210008, China
Ningbo First Hospital

Ningbo, China
Ningbo Medical Center Lihuili Hospital

Ningbo, China
The First Affiliated Hospital of Soochow University

Suzhou, China
The Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, China
Wenzhou Central Hospital

Wenzhou, China
Zibo Municipal Hospital

Zibo, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.